Equities

Kovo+Holdings Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert
KOVO:CVE

Kovo+Holdings Inc

Actions
  • Price (CAD)0.025
  • Today's Change0.00 / 0.00%
  • Shares traded500.00
  • 1 Year change-50.00%
  • Beta-0.3439
Data delayed at least 15 minutes, as of Feb 09 2026 17:19 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Kovo+ Holdings Inc. is a Canada-based technology company. The Company leads the charge in artificial intelligence (AI) initiatives to drive impact and innovation across diverse industries. The Company provides technology-enabled revenue cycle management solutions to healthcare providers, from small practices to enterprise medical groups, hospitals, and health systems throughout the United States. Its integrated platform includes revenue cycle management (RCM), practice management (PM), electronic health records (EHR), business intelligence, patient experience management solutions and complementary software tools and business services for high-performance medical groups and health systems. Its technology-enabled business solutions can be categorized as: Technology-enabled revenue cycle management, Implementing AI Automation, and Healthcare information technology (IT) professional services & staffing. The Company also offers printing and mailing and group purchasing services.

  • Revenue in CAD (TTM)14.73m
  • Net income in CAD-8.65m
  • Incorporated2020
  • Employees--
  • Location
    Kovo+Holdings Inc1600 - 925 West Georgia StreetVANCOUVER V6C 3L2CanadaCAN
  • Websitehttps://www.kovo.co/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
CardioComm Solutions Inc386.53k-404.82k1.98m16.00------5.11-0.0021-0.00210.002-0.00291.311.482.97---137.51-20.56----87.2583.20-104.73-9.130.2344-11.998.47---39.90-9.65-99.92---10.07--
Therma Bright Inc75.23k-4.16m3.13m--------41.53-0.0729-0.07290.0013-0.02480.04060.17260.3653---224.22-203.01-69,250.66-507.5765.25---5,523.12-9,158.610.1182-0.6815----207.9084.25-77.17------
Zero Candida Technologies Inc-100.00bn-100.00bn3.44m----2.09----------0.0839----------------------------0.0174--------------
Kovo+Holdings Inc14.73m-8.65m4.43m--------0.3005-0.054-0.0540.0921-0.0580.8026--33.43---47.17-----------58.77-----0.7981.60--5.45---25.26------
NuGen Medical Devices Inc589.43k-2.12m6.83m12.00------11.56-0.0092-0.00920.0026-0.03810.04610.783919.59---16.58---20.05--54.97---359.36--3.90--1.90--204.73--44.18------
VVT Med Inc9.53k-3.18m14.43m10.00------1,510.85-0.1053-0.10530.0005-0.01180.0072-------241.79437.87----71.43---33,401.511,850.650.6354-19.392.530.00----15.43------
Medx Health Corp522.91k-5.30m18.08m--------34.49-0.0187-0.01870.0018-0.03320.49080.865113.37---497.63-619.54----33.6045.55-1,013.97-858.590.0567-1.70----7.37-10.6620.25------
Data as of Feb 09 2026. Currency figures normalised to Kovo+Holdings Inc's reporting currency: Canadian Dollar CAD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.